Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
DisGeNET
DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
| Source | Last Updated |
|---|---|
| DisGeNET | July 29, 2024 |
| Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
|---|---|---|---|---|---|
| C0221166 | Paraparesis | CNTN3 | 5067 | contactin 3 | Q9P232 |
| C0086132 | Depressive Symptoms | CNTN3 | 5067 | contactin 3 | Q9P232 |
| C0011991 | Diarrhea | CNTN3 | 5067 | contactin 3 | Q9P232 |
| C0003469 | Anxiety Disorders | CNTN3 | 5067 | contactin 3 | Q9P232 |
| C0022661 | Kidney Failure, Chronic | CNTN3 | 5067 | contactin 3 | Q9P232 |
| C0023976 | Long QT Syndrome | CNTN3 | 5067 | contactin 3 | Q9P232 |
| C0028754 | Obesity | CNTN3 | 5067 | contactin 3 | Q9P232 |
| C0162820 | Dermatitis, Allergic Contact | CNTN3 | 5067 | contactin 3 | Q9P232 |
| C0007194 | Hypertrophic Cardiomyopathy | CNTN3 | 5067 | contactin 3 | Q9P232 |
| C0340427 | Familial dilated cardiomyopathy | CNTN3 | 5067 | contactin 3 | Q9P232 |
| C0028756 | Obesity, Morbid | CNTN3 | 5067 | contactin 3 | Q9P232 |
| C1621958 | Glioblastoma Multiforme | CNTN3 | 5067 | contactin 3 | Q9P232 |
| C1704436 | Peripheral Arterial Diseases | CNTN3 | 5067 | contactin 3 | Q9P232 |
| C2239176 | Liver carcinoma | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
| C0027651 | Neoplasms | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
| C0006826 | Malignant Neoplasms | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
| C0546837 | Malignant neoplasm of esophagus | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
| C0152018 | Esophageal carcinoma | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
| C1848296 | DOSAGE-SENSITIVE SEX REVERSAL | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
| C0009402 | Colorectal Carcinoma | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
| C1333762 | Gastric Cardia Adenocarcinoma | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
| C0278701 | Gastric Adenocarcinoma | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
| C1306459 | Primary malignant neoplasm | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
| C0017668 | Focal glomerulosclerosis | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
| C0268237 | Cytochrome-c Oxidase Deficiency | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
